AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
Optimization of retroviral vector generation for clinical application
Authors: Schilz, AJ Kuhlcke, K Fauser, AA Eckert, HG
Citation: Aj. Schilz et al., Optimization of retroviral vector generation for clinical application, J GENE MED, 3(5), 2001, pp. 427-436
Toxoplasmosis, a severe complication in allogeneic hematopoietic stem celltransplantation: Successful treatment strategies during a 5-year single-center experience
Authors: Roemer, E Blau, IW Basara, N Kiehl, MG Bischoff, M Gunzelmann, S Kirsten, D Sanchez, H Wocker, EL Fauser, AA
Citation: E. Roemer et al., Toxoplasmosis, a severe complication in allogeneic hematopoietic stem celltransplantation: Successful treatment strategies during a 5-year single-center experience, CLIN INF D, 32(1), 2001, pp. E1-E8
New therapeutic modalities in the treatment of graft-versus-host disease
Authors: Basara, N Kiehl, MG Fauser, AA
Citation: N. Basara et al., New therapeutic modalities in the treatment of graft-versus-host disease, CR R ONC H, 38(2), 2001, pp. 129-138
Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells
Authors: Knipper, R Kuehlcke, K Schiedlmeier, B Hildinger, M Lindemann, C Schilz, AJ Fauser, AA Fruehauf, S Zeller, WJ Ostertag, W Eckert, HG Baum, C
Citation: R. Knipper et al., Improved post-transcriptional processing of an MDR1 retrovirus elevates expression of multidrug resistance in primary human hematopoietic cells, GENE THER, 8(3), 2001, pp. 239-246
Successful treatment of thrombocytopenia and hemolytic anemia with IvIG ina patient with lupus-like syndrome after mismatched related PBSCT
Authors: Hartert, A Willenbacher, W Gunzelmann, S Roemer, E Basara, N Fauser, AA Kiehl, MG
Citation: A. Hartert et al., Successful treatment of thrombocytopenia and hemolytic anemia with IvIG ina patient with lupus-like syndrome after mismatched related PBSCT, BONE MAR TR, 27(3), 2001, pp. 337-340
Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study
Authors: Blau, IAW Basara, N Lentini, G Guenzelmann, S Kirsten, D Schmetzer, B Bischoff, M Roemer, E Kiehl, MG Fauser, AA
Citation: Iaw. Blau et al., Feasibility and safety of peripheral blood stem cell transplantation from unrelated donors: results of a single-center study, BONE MAR TR, 27(1), 2001, pp. 27-33
Mycophenolate mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: Four years of experience
Authors: Basara, N Kiehl, MG Blau, W Romer, E Bischoff, M Schmetzer, B Kirsten, D Gunzelmann, S Fauser, AA
Citation: N. Basara et al., Mycophenolate mofetil in the treatment of acute and chronic GVHD in hematopoietic stem cell transplant patients: Four years of experience, TRANSPLAN P, 33(3), 2001, pp. 2121-2123
New immunosuppressants in BMT/GVHD
Authors: Basara, N Gunzelmann, S Willenbacher, W Fauser, AA Kiehl, MG
Citation: N. Basara et al., New immunosuppressants in BMT/GVHD, TRANSPLAN P, 33(3), 2001, pp. 2220-2222
Factor XIII replacement in stem cell transplant (SCT) recipients with severe graft-versus-host disease of the bowel: Report of an initial experience
Authors: Grothaus-Pinke, B Gunzelmann, S Fauser, AA Kiehl, MG
Citation: B. Grothaus-pinke et al., Factor XIII replacement in stem cell transplant (SCT) recipients with severe graft-versus-host disease of the bowel: Report of an initial experience, TRANSPLANT, 72(8), 2001, pp. 1456-1458
Anti-emetics for cancer chemotherapy-induced emesis - Potential of alternative delivery systems
Authors: Kraut, L Fauser, AA
Citation: L. Kraut et Aa. Fauser, Anti-emetics for cancer chemotherapy-induced emesis - Potential of alternative delivery systems, DRUGS, 61(11), 2001, pp. 1553-1562
Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab
Authors: Willenbacher, W Basara, N Blau, IW Fauser, AA Kiehl, MG
Citation: W. Willenbacher et al., Treatment of steroid refractory acute and chronic graft-versus-host disease with daclizumab, BR J HAEM, 112(3), 2001, pp. 820-823
No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors
Authors: Remberger, M Ringden, O Blau, IW Ottinger, H Kremens, B Kiehl, MG Aschan, J Beelen, DW Basara, N Kumlien, G Fauser, AA Runde, V
Citation: M. Remberger et al., No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors, BLOOD, 98(6), 2001, pp. 1739-1745
MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions
Authors: Schilz, AJ Schiedlmeier, B Kuhlcke, K Fruehauf, S Lindemann, C Zeller, WJ Grez, M Fauser, AA Baum, C Eckert, HG
Citation: Aj. Schilz et al., MDR1 gene expression in NOD/SCID repopulating cells after retroviral gene transfer under clinically relevant conditions, MOL THER, 2(6), 2000, pp. 609-618
A double-blind, randomised, parallel study comparing intravenous dolasetron plus dexamethasone and intravenous dolasetron alone for the management offractionated cisplatin-related nausea and vomiting
Authors: Fauser, AA Pizzocaro, G Schueller, J Khayat, D Wilkinson, P
Citation: Aa. Fauser et al., A double-blind, randomised, parallel study comparing intravenous dolasetron plus dexamethasone and intravenous dolasetron alone for the management offractionated cisplatin-related nausea and vomiting, SUPP CARE C, 8(1), 2000, pp. 49-54
Review of comparative studies between conventional and liposomal amphotericin B (Ambisome (R)) in neutropenic patients with fever of unknown origin and patients with systemic mycosis
Authors: Blau, IW Fauser, AA
Citation: Iw. Blau et Aa. Fauser, Review of comparative studies between conventional and liposomal amphotericin B (Ambisome (R)) in neutropenic patients with fever of unknown origin and patients with systemic mycosis, MYCOSES, 43(9-10), 2000, pp. 325-332
Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients
Authors: Basara, N Blau, WI Kiehl, MG Schmetzer, B Bischoff, M Kirsten, D Gunzelmann, S Fauser, AA
Citation: N. Basara et al., Mycophenolate mofetil for the prophylaxis of acute GVHD in HLA-mismatched bone marrow transplant patients, CLIN TRANSP, 14(2), 2000, pp. 121-126
Safety profile of mycophenolate mofetil
Authors: Basara, N Fauser, AA
Citation: N. Basara et Aa. Fauser, Safety profile of mycophenolate mofetil, BONE MAR TR, 26(12), 2000, pp. 1362-1363
Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study
Authors: Basara, N Schmetzer, B Blau, IW Bischoff, M Gunzelmann, S Kirsten, D Fauser, AA
Citation: N. Basara et al., Lenograstim-mobilized peripheral blood progenitor cells in volunteer donors: an open label randomized split dose escalating study, BONE MAR TR, 25(4), 2000, pp. 371-376
2nd International Symposium on Transplantation & Gene Therapy - October 21-23, 1999 - Idar-Oberstein, Germany - Preface
Authors: Fauser, AA Kiehl, MG
Citation: Aa. Fauser et Mg. Kiehl, 2nd International Symposium on Transplantation & Gene Therapy - October 21-23, 1999 - Idar-Oberstein, Germany - Preface, BONE MAR TR, 25, 2000, pp. S1-S1
Faster engraftment of neutrophils and platelets with peripheral blood stemcells from unrelated donors: a comparison with marrow transplantation
Authors: Ringden, O Remberger, M Runde, V Bornhauser, M Blau, IW Basara, N Holig, K Beelen, DW Hagglund, B Basu, O Ehninger, G Fauser, AA
Citation: O. Ringden et al., Faster engraftment of neutrophils and platelets with peripheral blood stemcells from unrelated donors: a comparison with marrow transplantation, BONE MAR TR, 25, 2000, pp. S6-S8
New strategies in the treatment of graft-versus-host disease
Authors: Basara, N Blau, IW Willenbacher, W Kiehl, MG Fauser, AA
Citation: N. Basara et al., New strategies in the treatment of graft-versus-host disease, BONE MAR TR, 25, 2000, pp. S12-S15
New strategies in GVHD prophylaxis
Authors: Kiehl, MG Shipkova, M Basara, N Blau, WI Fauser, AA
Citation: Mg. Kiehl et al., New strategies in GVHD prophylaxis, BONE MAR TR, 25, 2000, pp. S16-S19
A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): a single center study
Authors: Fauser, AA Basara, N Blau, IW Kiehl, MG
Citation: Aa. Fauser et al., A comparative study of peripheral blood stem cell vs bone marrow transplantation from unrelated donors (MUD): a single center study, BONE MAR TR, 25, 2000, pp. S27-S31
Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic stem cell transplantation
Authors: Kuhlcke, K Ayuk, FA Li, Z Lindemann, C Schilz, A Schade, UM Fauser, AA Zander, AR Eckert, HG Fehse, B
Citation: K. Kuhlcke et al., Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic stem cell transplantation, BONE MAR TR, 25, 2000, pp. S96-S98
Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1)
Authors: Eckert, HG Kuhlcke, K Schilz, AJ Lindemann, C Basara, N Fauser, AA Baum, C
Citation: Hg. Eckert et al., Clinical scale production of an improved retroviral vector expressing the human multidrug resistance 1 gene (MDR1), BONE MAR TR, 25, 2000, pp. S114-S117
Risultati: 1-25 | 26-36